市場調査レポート

商品コード

1527795

生殖補助医療の市場規模、シェア、成長分析、技術別、手順別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

Assisted Reproductive Technology Market Size, Share, Growth Analysis, By Technique(In Vitro Fertilization, Artificial Insemination, Frozen Embryo Transfer, Others), By Procedure, By End User, By Region - Industry Forecast 2024-2031

出版日: 2024年07月23日
発行: SkyQuest
ページ情報: 英文 165 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 779,047円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 911,338円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,043,629円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.99円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界の生殖補助医療市場は、2022年に253億米ドルとなり、2023年の266億7,000万米ドルから上昇し、予測期間（2024年～2031年）のCAGRは5.40%で、2031年までには406億7,000万米ドルに達すると予測されています。

世界の生殖補助医療（ART）市場は、いくつかの重要な要因によって顕著な成長を遂げています。不妊率の上昇、医療技術の進歩、ART治療に対する認識と受容の高まりが、この拡大に大きく寄与しています。ライフスタイルの変化、妊娠の遅れ、環境の影響、様々な病状により、不妊治療を求める人が増えており、体外受精（IVF）、顕微授精（ICSI）、配偶子提供などのART処置の需要を押し上げています。タイムラプス画像システムや、組成や安定性を高めた胚培養液の改良といった革新的技術の採用が、ART治療の成功率を大幅に高めています。これらの進歩は、胚の発育をよりよくモニターし最適化するのに役立ち、ひいては治療成績の向上につながります。さらに、ARTの受け入れが拡大していることも市場の成長を後押ししています。歴史的には、不妊やARTを取り巻く社会的烙印が、その利用を阻む障壁となっていました。しかし、社会的な考え方の変化や教育的な取り組み、支援団体の存在により、ARTは不妊の課題に直面しているカップルにとって合法的で効果的な選択肢であることが認知されるようになりました。このような受容の高まりにより、不妊治療を受ける人が増え、ARTサービスの需要が高まり、市場はさらに拡大しています。

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- イタリア
- 英国
- その他欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主要な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

Vitrolife AB（Sweden）
CooperSurgical, Inc.（US）
Cook Medical, Inc.（US）
Irvine Scientific（US）
Genea Limited（Australia）
Ferring Pharmaceuticals（Switzerland）
Merck KGaA（Germany）
Thermo Fisher Scientific, Inc.（US）
Esco Group（Singapore）
Hamilton Thorne, Inc.（Canada）
Nidacon International AB（Sweden）
Kitazato Corporation（Japan）
OvaScience（US）
The Cooper Companies, Inc.（US）
IGENOMIX（Spain）
IVFtech ApS（Denmark）
Origio a/s（Denmark）
Cryolab Ltd.（United Kingdom）
Anecova（Switzerland）
Progyny, Inc.（US）

Product Code: SQMIG35G2228

Global assisted reproductive market was valued at USD 25.30 billion in 2022 and is expected to rise from USD 26.67 billion in 2023 to reach a value of USD 40.67 billion by 2031, at a CAGR of 5.40% during the forecast period (2024-2031).

The global assisted reproductive technology (ART) market is experiencing notable growth, driven by several key factors. Rising infertility rates, advances in medical technology, and increasing awareness and acceptance of ART procedures are major contributors to this expansion. Changing lifestyles, delayed pregnancies, environmental influences, and various medical conditions are leading more individuals to seek fertility treatments, thereby boosting the demand for ART procedures such as in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and gamete donation. The introduction of innovative technologies, such as time-lapse imaging systems and improved embryo culture media with enhanced composition and stability, has significantly increased the success rates of ART procedures. These advancements help in better monitoring and optimizing embryo development, which in turn improves outcomes. Additionally, the growing acceptance of ART is fueling market growth. Historically, social stigma surrounding infertility and ART procedures created barriers to their use. However, shifting societal attitudes, along with educational initiatives and support groups, have helped normalize ART as a legitimate and effective option for couples facing infertility challenges. This increased acceptance has led to more individuals pursuing fertility treatments, thereby driving the demand for ART services and further expanding the market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Assisted Reproductive market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Assisted Reproductive Market Segmental Analysis

The assisted reproductive technology (ART) market is segmented by type, application, and region. Based on type, the market can be segmented into in vitro fertilization (IVF) (fresh donor, frozen donor, fresh non-donor, frozen non-donor), artificial insemination (intrauterine insemination, intracervical insemination, intravaginal insemination, intratubal insemination) and surrogacy. Based on end use, the market is segmented into fertility clinics, hospitals, specialized ART centers, and research institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Assisted Reproductive Market

The global assisted reproductive technology (ART) market is expanding significantly due to rising infertility rates worldwide. Factors such as changing lifestyles, delayed pregnancies, and environmental influences contribute to the increasing demand for ART. These technologies provide solutions for individuals and couples facing fertility challenges, helping them achieve their goal of conceiving.

Restraints in the Global Assisted Reproductive Market

Ethical and legal concerns present significant challenges for the ART market, especially in certain regions. The application of ART procedures raises various ethical issues and is subject to diverse regulations. Key concerns include the appropriate disposal of embryos, the extent of donor anonymity, and the regulation of emerging techniques such as gamete and embryo editing. These issues can affect the availability and acceptance of specific ART procedures and, consequently, influence market dynamics.

Market Trends of the Global Assisted Reproductive Market

A notable trend in the global Assisted Reproductive Technology (ART) market is the rising demand for advanced genetic testing and screening technologies. As reproductive medicine progresses, there is an increasing focus on ensuring the health and viability of embryos before implantation. Techniques like preimplantation genetic screening (PGS) and preimplantation genetic diagnosis (PGD) are becoming more prominent as they help identify genetic abnormalities and chromosomal disorders in embryos. This trend is fueled by couples' desire for healthy children and growing awareness of how genetic testing can enhance the success rates of ART procedures.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Case Study Analysis
Ecosystem of the Market
Regulatory Landscape
PESTEL Analysis
Innovation Matrix
Top Investment Analysis
Key Success Factor
Market Attractive Index
Degree of Competition

Assisted Reproductive Technology (ART) Market by Type

Market Overview
In vitro fertilization (IVF)
- Fresh Donor
- Frozen Donor
- Fresh non-Donor
- Frozen non-Donor
Artificial Insemination
- Intrauterine Insemination
- Intracervical Insemination
- Intravaginal Insemination
- Intratubal Insemination
Surrogacy

Assisted Reproductive Technology (ART) Market by End Use

Market Overview
Fertility clinics
Hospitals
Specialized ART centers
Research institutes

Assisted Reproductive Technology (ART) Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- Italy
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Vitrolife AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CooperSurgical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Irvine Scientific (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genea Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ferring Pharmaceuticals (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Esco Group (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hamilton Thorne, Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nidacon International AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kitazato Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OvaScience (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
The Cooper Companies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IGENOMIX (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IVFtech ApS (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Origio a/s (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cryolab Ltd. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Anecova (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Progyny, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

生殖補助医療の市場規模、シェア、成長分析、技術別、手順別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

Assisted Reproductive Technology Market Size, Share, Growth Analysis, By Technique(In Vitro Fertilization, Artificial Insemination, Frozen Embryo Transfer, Others), By Procedure, By End User, By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主要な市場の考察

生殖補助医療（ART）市場：タイプ別

生殖補助医療（ART）市場：最終用途別

生殖補助医療（ART）市場規模：地域別